Interestingly, when MIG-6 was downregulated in mutant EGFR lung cancer cells under hypoxic conditions, EGFR signalling was restored, promoting the phosphorylation of ERK and AKT through increased EGFR-HER3 binding, as well as their sensitivity to EGFR-TKI and radiation. The gene discussed is AKT1; the disease is lung cancer.